A Study Comparing the Combination of Trabectedin (YONDELIS) and DOXIL/CAELYX With DOXIL/CAELYX for the Treatment of Advanced-Relapsed Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

Clinical trial NCT01846611 · COMPLETED

Trial details

NCT number: NCT01846611
Sponsor: Janssen Research & Development, LLC
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Ovarian Neoplasms Peritoneal Neoplasms Fallopian Tube Neoplasms

Start date: 2013-10-16
Primary completion: 2018-01-18
Enrollment: 581

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.